Adsorption and Effectiveness of Different Antibiotics on Pure Hydroxyapatite (HA) with Controlled Porosity


Article Preview

The advantages of local antibiotic administration - high local levels with low systemic toxicity - are nowadays recognized as an efficient way for anti-infection therapies consecutive to the orthopaedic implant surgery. Aimed at assessing the feasibility of using Hydroxyapatite as drugdelivery carrier in addition to its well-known bone reconstruction bioactivity, a pure HA ceramic with specific internal pore size and porosities was under our investigation. The antibiotic release and antibacterial effect were determined by UV spectrophotometry and disk agar diffusion assays after impregnation with different antibiotics and their release in different solvents. No differences were found after the ATB impregnation under normal pressure or under vacuum conditions. The influences of impregnation time on the duration of the ATB release and on the antibacterial efficiency were more evident for Vancomycin than for Ciprofloxacin and Gentamycin. In all cases, the ATBs penetrated micro-porous and meso-porous HA samples and showed significantly stronger and longer anti-bacterial effects than dense HA samples. The ATBs releases in PBS were relatively slower and the antibacterial effectiveness subsequently prolonged with respect to those in human plasma. All tested HA samples with or without ATB impregnation exhibited very good biocompatibility as shown by cell proliferation tests. It revealed a promising perspective for further improving the antibacterial efficiency by other surface functionalization methods for achieving a controllable drug delivery with antibiotic loaded HA.



Key Engineering Materials (Volumes 330-332)

Main Theme:

Edited by:

Xingdong Zhang, Xudong Li, Hongsong Fan, Xuanyong Liu




F. Chai et al., "Adsorption and Effectiveness of Different Antibiotics on Pure Hydroxyapatite (HA) with Controlled Porosity", Key Engineering Materials, Vols. 330-332, pp. 1013-1016, 2007

Online since:

February 2007




[1] J. Ciampolini and K.G. Harding: Postgrad. Med. J. 76 (898) (2000), p.479.

[2] K. Kanellakopoulou and E.J. Giamarellous-Bourboulis: Drugs Vol. 59 (2000), p.1223.

[3] M.A. Rauschmanna, T.A. Wichelhausb, V Stirnalc, E Dingeldeinc, L. Zichnera, R. Schnettlerd and V. Alt: �Biomaterials Vol. 26 (2005), p.2677.

[4] A.C. Queiroz, J.D. Santos, F.J. Monteiro and J.C. Knowles: Biomaterials Vol. 22 (2001), 1393.

[5] C. Zhou, C. Wang, M. Descamps and J. Lu: J Biomed Eng. Vol. 19 (2002), p.9.

[6] D. J. Biedenbach, and R. N. Jones: J Clin Microbiol, Vol. 35 (1997), p.3198.

[7] J.C. Hornez, A. Lefevre, D. Joly and H.F. Hildebrand: J. Biomol. Eng. Vol. 19 (2002), p.103.

[8] H.F. Hildebrand, N. Blanchemain, G. Mayer, F. Chai, M. Lefebvre and F Boschin: Surface & Coatings Technology Vol. 200 (2006), p.6318.

DOI: 10.1016/j.surfcoat.2005.11.086

[9] N. Blanchemain, S. Haulon, B. Martel, M. Traisnel, M. Morcellet and H.F. Hildebrand: Europ. J Vasc. Endovasc. Surg. Vol. 29 (2005), p.628.

Fetching data from Crossref.
This may take some time to load.